Christian Ruff, MD, highlights pharmacists as essential clinical partners who help optimize drug selection, dosing, and safety for patients with complex needs.
Christian Ruff, MD, MPH
Advertisement
Christian Ruff, MD, MPH, is director of general cardiology at Brigham and Women's Hospital.
Articles by Christian Ruff, MD, MPH
Christian Ruff, MD, highlights abelacimab’s potential to significantly reduce bleeding in patients with high-risk atrial fibrillation.
Pharmacists should educate patients on abelacimab's potential therapeutic impact on atrial fibrillation patients at risk of stroke.
Christian Ruff explains the strong efficacy associated with abelacimab compared with rivaroxaban in the AZALEA-TIMI 71 trial.
Advertisement
Latest Updated Articles
Expert: Pharmacists Play Key Role in Abelacimab Adoption, Adherence as Data Shows Promise in Atrial FibrillationPublished: February 10th 2025 | Updated:
Expert: Abelacimab Shows Significant Bleeding Reduction, Offering Safer Option for Atrial Fibrillation TreatmentPublished: February 5th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
GLP-1 Agonists May Interfere with PET-CT Scan Interpretation
2
Tramadol and Antidepressants Linked to Increased Seizure Risk in Older Adults
3
FDA Approvals for September 2025
4
Psychedelics Provide Insights Into Lewy Body Diseases' Hallucinations
5
